Genmab A/S

WHO'M

Digital Profiler. Simply click the AI button

CUSIP

K3967W102

SEDOL

4595739

CIK

N/A

genmab.com

LEI:

FIGI: BBG000BKPC99

GMAB

Genmab A/S

GICS: 35201010 · Sector: Health Care · Sub-Sector: Health Care

NAME

Genmab A/S

ISIN

DK0010272202

TICKER

GMAB

MIC

XCSE

REUTERS

GMAB.CO

BLOOMBERG

GMAB DC

BUILD THEMEFOLIO SHARE IDEAS DISCUSS

LEVERAGE INVEST

Financial Intelligence

360°^iHub Crowd^iFeed ATH Tracker Index Tracker ETF TF Spicy² X-Billboard

FOR INVESTORS

FOR TRADERS

Securities Trading Warrants

GlobeNewswire is an important news source that provides investors with company-related information. In particular, it deals with events that may be relevant to the listing of companies or tradable financial instruments. You can access the complete overview of all reports via this link.

Mon, 25.11.2024

Media Release

COPENHAGEN, Denmark; November 25, 2024

Research & Analysis

Thu, 21.11.2024

Company Announcement

Research & Analysis

Wed, 06.11.2024

November 6, 2024 Copenhagen, Denmark;
Interim Report for the First Nine Months Ended September 30, 2024

Research & Analysis

Tue, 05.11.2024

Media Release

COPENHAGEN, Denmark; November 5, 2024

Research & Analysis

Tue, 15.10.2024

Company Announcement

Research & Analysis

Fri, 04.10.2024

Company Announcement

Research & Analysis

Thu, 26.09.2024

Company Announcement

Research & Analysis

Sun, 15.09.2024

Media Release

COPENHAGEN, Denmark; September 15, 2024

Research & Analysis

Tue, 10.09.2024

Company Announcement

Research & Analysis

Mon, 26.08.2024

Media Release

COPENHAGEN, Denmark; August 26, 2024

Research & Analysis

We are different

OPEN FINANCIAL

DATA & KNOWLEDGE HUB

We make the difference

Information on product placements

Legend

First Name *

Last Name

Email *

Subject *

i.e Feature x is not working

Issue happened on *

This page

Other page

Bug Detail *

Please give us more detailed explanation of the issue

Steps to reproduce *

Specify the steps you've done before the issue happen

Actual Result *

What's the result of the issue?

Expected Result *

What do you expect to see?

Attachment

(Optional) You can send us a screenshot, word document, or a PDF explaining the issue

Please log in to your user account. This will allow us to contact you in case of any queries.

I would like to remain anonymous.

Genmab A/S

Genmab to Present at Citi’s Global Healthcare Conference

Grant of Restricted Stock Units and Warrants to Employees in Genmab

Genmab Announces Financial Results for the First Nine Months of 2024

Genmab to Present at Jefferies London Healthcare Conference

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2024

Major Shareholder Announcement

Grant of Restricted Stock Units and Warrants to Employees in Genmab

Investigational Rinatabart Sesutecan (Rina-S) Shows Promising Anti-Tumor Activity as Single Agent in Heavily Pretreated Patients with Ovarian and Endometrial Cancers in Phase 1/2 Clinical Trial

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

Newsletter